Morgan Stanley upgrades ITM Power, raises PT to 170p on profitability outlook

Morgan Stanley upgraded ITM Power to overweight and lifted its price target to 170p from 60p, implying roughly 183% upside versus the prior target. The bank now sees FY28 EBITDA of £13 million versus a £4 million consensus loss and FY28 revenue of £169 million, 54% above consensus, with breakeven expected one year earlier than the market. The call was supported by a lower 9% WACC, higher long-term market share assumptions, and a catalyst-rich 2026 pipeline including UK hydrogen auction results and project FIDs.

Analysis

The read-through is less about a single hydrogen OEM and more about a re-rating of the entire green H2 capex complex: if a credible broker moves from “survival optionality” to a path toward breakeven, the market will start valuing balance-sheet runway and order conversion instead of just gross margin volatility. That is constructive for the few listed electrolyzer-adjacent names with net cash and manufacturing visibility, while it is punitive for weaker private competitors that need equity before scale, because the bar for financing just moved higher.

The second-order effect is on supply chain leverage. If 2026 actually becomes a catalyst year for project FIDs, the bottleneck shifts from technology validation to industrial execution: power electronics, compression, balance-of-plant, and high-spec steel/fabrication capacity should see tighter quoting and better terms. That tends to favor upstream component suppliers with multi-year contract coverage more than the OEM itself, since OEMs will still absorb warranty and working-capital drag while the ecosystem re-prices capacity.

The key risk is that the rerating is being driven by long-dated assumptions rather than near-term cash generation, so any delay in public-sector allocation rounds or project FIDs can compress the multiple quickly. This is a classic 6-12 month catalyst trade with binary headline risk: if 2026 order flow disappoints, the market will refocus on cash burn and the stock can easily give back most of the WACC-driven uplift. Conversely, if the next two order announcements merely confirm modest traction, the stock likely still works because the market is currently paying for a lower probability of dilution, not for imminent profitability.

Consensus may be missing that the biggest upside is not in the OEM margin line but in financing optionality. A large net-cash cushion buys time, but the real inflection is when the company can fund growth without repeated equity raises; that alone can add multiple turns of EV/revenue. The move looks somewhat underdone if 2026 catalysts land, but overdone if investors extrapolate today’s balance-sheet strength into a clean 2028 earnings profile without accounting for slippage, project timing, and manufacturing capex intensity.

Key Decisions for Investors

• Long ITM Power (ITM) on weakness, sized as a 6-12 month catalyst trade; use a 15-20% drawdown stop because the thesis is driven by delayed FID/order headlines rather than quarterly fundamentals.
• Pair trade: long ITM / short a weaker hydrogen OEM or renewables pre-profit name with tighter funding runway; the relative trade benefits if the market rewards balance-sheet optionality over pure growth narratives.
• Buy call spreads on ITM into the 2026 catalyst window (e.g., 9-12 month tenor) to express upside from order announcements while capping theta bleed; target a 2:1 to 3:1 payoff if multiple expansion continues.
• If exposed to the broader clean-tech basket, rotate toward component/supply-chain beneficiaries rather than OEMs; the better risk/reward is in businesses that gain from higher project activity without needing perfect execution.
• Set a hard review point after the next major allocation/FID milestone: if order intake fails to inflect by then, trim the long because the market will likely reprice the stock back to a cash-burn story.